Authors:
ANTHONY MT
ZEIGLER ZR
LISTER J
RAYMOND JM
SHADDUCK RK
KRAMER RE
GRYN JF
RINTELS PB
BESA EC
GEORGE JN
SILVER B
JOYCE R
BODENSTEINER D
Citation: Mt. Anthony et al., PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) ANTIGEN LEVELS IN PRIMARY TTPAND SECONDARY TTP POST-BONE MARROW TRANSPLANTATION, American journal of hematology, 59(1), 1998, pp. 9-14
Authors:
ZEIGLER ZR
ROSENFELD CS
ANDREWS DF
NEMUNAITIS J
RAYMOND JM
SHADDUCK RK
KRAMER RE
GRYN JF
RINTELS PB
BESA EC
GEORGE JN
Citation: Zr. Zeigler et al., PLASMA VON-WILLEBRAND-FACTOR ANTIGEN (VWF-AG) AND THROMBOMODULIN (TM)LEVELS IN ADULT THROMBOTIC THROMBOCYTOPENIC PURPURA HEMOLYTIC-UREMIC SYNDROMES (TTP HUS) AND BONE-MARROW TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (BMT-TM)/, American journal of hematology, 53(4), 1996, pp. 213-220
Authors:
BOUCHER BA
FELER CA
DEAN C
MICHIE DD
TIPTON BK
SMITH KR
KRAMER RE
YOUNG B
PARKS BR
KUGLER AR
Citation: Ba. Boucher et al., THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF FOSPHENYTOIN AFTER INTRAMUSCULAR AND INTRAVENOUS ADMINISTRATION IN NEUROSURGERY PATIENTS, Pharmacotherapy, 16(4), 1996, pp. 638-645
Citation: Re. Kramer et al., POLYSOMNOGRAPHIC FINDINGS IN PATIENTS WITH QUADRIPLEGIA - CORRELATIONS WITH LEVEL OF SPINAL-CORD INJURY, Neurology, 45(4), 1995, pp. 286-286
Authors:
MATSUO F
BERGEN D
FAUGHT E
MESSENHEIMER JA
DREN AT
RUDD GD
LINEBERRY CG
MADSEN JA
RISTANOVIC R
ERENBERG G
KRAMER RE
HARNER RN
SCHOMER DL
LEPPIK I
COLLINS SD
KING KW
SHAMSNIA M
WHITE RL
GAY PE
ROTHNER AD
DRAKE ME
DETOLEDO J
SUSSMAN NM
MIKATI MA
OLSON D
FROMM G
MURRO AM
EHLE A
FOLEY JF
MORRIS HH
SMITH DB
SO EL
SCHACHTER SC
KUZNIECKY R
LAXER K
GALLAGHER BB
WEISBERG LA
MOORE EL
Citation: F. Matsuo et al., PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF LAMOTRIGINE INPATIENTS WITH PARTIAL SEIZURES, Neurology, 43(11), 1993, pp. 2284-2291
Citation: Re. Kramer, EFFECTS OF DILTIAZEM ON CALCIUM-METABOLISM IN CULTURED BOVINE GLOMERULOSA CELLS - RELATIONSHIPS TO THE ACTIONS OF ANGIOTENSIN-II AND POTASSIUM, The Journal of pharmacology and experimental therapeutics, 266(1), 1993, pp. 374-384